Literature DB >> 25864805

Construct validity and clinical utility of current research criteria of DSM-5 somatic symptom disorder diagnosis in patients with fibromyalgia syndrome.

Winfried Häuser1, Patric Bialas2, Katja Welsch2, Frederick Wolfe3.   

Abstract

OBJECTIVE: The validity and clinical utility of current research criteria of the DSM 5 category somatic symptom disorder (SSD) needs to be tested outside the setting of psychiatry.
METHODS: Consecutive patients with an established diagnosis of fibromyalgia syndrome (FMS) were evaluated by medical examination, psychiatric interview and self-report questionnaires in an outpatient pain medicine center. The diagnosis of SSD was established using published research criteria. The discriminative concurrent criterion validity of SSD was tested by comparing FMS-patients with and without SSD as to the amount of impairment and of health care seeking. Two clinicians blinded as to the purpose of the study, assessed the medical reports of patients after the evaluation for the determination of the need for psychotherapy based on the German FMS - guideline recommendations (clinical utility).
RESULTS: 25.6% of 156 patients met the criteria of SSD. Patients meeting SSD criteria scored significantly higher in a self-report measure of disability. There were no significant differences in the number of patients on sick leave or applying for disability pension and in self-reported doctor visits and physiotherapy in the previous six months. 95.0% of patients with SSD and 71.6% of patients without SSD met the criteria of a current anxiety or depressive disorder as assessed by the psychiatric interview. 80.0% of patients with SSD and 66.7% of patients without SSD received a recommendation for psychotherapy.
CONCLUSIONS: The construct validity and clinical utility of current research criteria of DSM 5 category SSD were limited in German patients with FMS.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  anxiety; clinical utility; depression; fibromyalgia syndrome; somatic symptom disorder; validity

Mesh:

Year:  2015        PMID: 25864805     DOI: 10.1016/j.jpsychores.2015.03.151

Source DB:  PubMed          Journal:  J Psychosom Res        ISSN: 0022-3999            Impact factor:   3.006


  9 in total

Review 1.  [Definition, classification, clinical diagnosis and prognosis of fibromyalgia syndrome : Updated guidelines 2017 and overview of systematic review articles].

Authors:  W Eich; K-J Bär; M Bernateck; M Burgmer; C Dexl; F Petzke; C Sommer; A Winkelmann; W Häuser
Journal:  Schmerz       Date:  2017-06       Impact factor: 1.107

2.  A-MUPS score to differentiate patients with somatic symptom disorder from those with medical disease for complaints of non-acute pain.

Authors:  Shingo Suzuki; Yoshiyuki Ohira; Kazutaka Noda; Masatomi Ikusaka
Journal:  J Pain Res       Date:  2017-06-07       Impact factor: 3.133

Review 3.  Management of somatic symptom disorder.

Authors:  Peter Henningsen
Journal:  Dialogues Clin Neurosci       Date:  2018-03       Impact factor: 5.986

Review 4.  Facts and myths pertaining to fibromyalgia.

Authors:  Winfried Häuser; Mary-Ann Fitzcharles
Journal:  Dialogues Clin Neurosci       Date:  2018-03       Impact factor: 5.986

5.  Health Care Use and Costs of Children, Adolescents, and Young Adults With Somatic Symptom and Related Disorders.

Authors:  Natasha Ruth Saunders; Sima Gandhi; Simon Chen; Simone Vigod; Kinwah Fung; Claire De Souza; Hana Saab; Paul Kurdyak
Journal:  JAMA Netw Open       Date:  2020-07-01

6.  Evaluating Commonalities Across Medically Unexplained Symptoms.

Authors:  Dan Guo; Maria Kleinstäuber; Malcolm Henry Johnson; Frederick Sundram
Journal:  Int J Environ Res Public Health       Date:  2019-03-06       Impact factor: 3.390

7.  Medically Unexplained Symptoms (MUS): Faults and Implications.

Authors:  Michiel Tack
Journal:  Int J Environ Res Public Health       Date:  2019-04-08       Impact factor: 3.390

Review 8.  Somatic symptom disorder: a scoping review on the empirical evidence of a new diagnosis.

Authors:  Bernd Löwe; James Levenson; Miriam Depping; Paul Hüsing; Sebastian Kohlmann; Marco Lehmann; Meike Shedden-Mora; Anne Toussaint; Natalie Uhlenbusch; Angelika Weigel
Journal:  Psychol Med       Date:  2021-11-15       Impact factor: 7.723

9.  Operationalization of diagnostic criteria of DSM-5 somatic symptom disorders.

Authors:  Nana Xiong; Yaoyin Zhang; Jing Wei; Rainer Leonhart; Kurt Fritzsche; Ricarda Mewes; Xia Hong; Jinya Cao; Tao Li; Jing Jiang; Xudong Zhao; Lan Zhang; Rainer Schaefert
Journal:  BMC Psychiatry       Date:  2017-11-07       Impact factor: 3.630

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.